Weekly injections of B12 over 24 weeks significantly improved neurological disability in patients with MS in a randomized controlled experiment, showing improvements after two weeks of treatment, which were further improved by the addition of lofepramine and l-phenylalanine [137]

Water(Aqua), Glycerin, Dipropylene Glycol, Hydrogenated Polydecene, Methylpropanediol, Niacinamide, Cetyl Ethylhexanoate, Chondrus Crispus, Acrylates Copolymer, Ceratonia Siliqua (Carob) Gum, Betaine, 1,2-Hexanediol, Hydroxyacetophenone, Panthenol, Butyrospermum Parkii (Shea) Butter, Potassium Chloride, Polyglyceryl-3 Methylglucose Distearate, Cetyl Hydroxyethylcellulose, Sucrose, Sodium Polyacrylate, Allantoin, Glutathione(1,000ppm), Ethylhexylglycerin, Adenosine, Dipotassium Glycyrrhizate, Fragrance(Parfum), Disodium EDTA, Ascorbyl Glucoside, Tranexamic Acid, Hydrated Silica, Butylene Glycol, Disodium Phosphate, Silica Dimethyl Silylate, Sodium Phosphate, Hydrolyzed Hyaluronic Acid, Phaseolus Radiatus Sprout Extract, Brassica Oleracea Italica (Broccoli) Sprout Extract, Brassica Campestris (Rapeseed) Sprout Extract, Caprylyl Glycol, Tocopherol, Hydrolyzed Vegetable Protein, Palmitoyl Tripeptide-5

FIGURE 4 FIGURE 5 FIGURE 6 FIGURE 7 FIGURE 8 The ACR criteria response rates were utilized for efficacy evaluation
Acknowledgements We want to publish via the subscription publishing route
R.TesiP